EMA Application withdrawn: Neofordex (dexamethasone) — Laboratoires CTRS - Boulogne Billancourt

View source ↗

Summary

Application for Neofordex (dexamethasone) withdrawn by Laboratoires CTRS for multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Neofordex (dexamethasone)

Snippet

Status: Application withdrawn. Therapeutic area: Multiple Myeloma. MAH: Laboratoires CTRS - Boulogne Billancourt. Decision date: 25/07/2014